|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| |||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Employee Stock Option (Right to buy) | $ 18.27 | 09/12/2018 | D | 66,593 (3) | 02/28/2013 | 02/28/2020 | Common Shares | 66,593 | $ 57.6 | 0 | D | ||||
Employee Stock Option (Right to buy) | $ 23.35 | 09/12/2018 | D | 61,539 (3) | 02/28/2014 | 02/28/2021 | Common Shares | 61,539 | $ 57.6 | 0 | D | ||||
Employee Stock Option (Right to buy) | $ 20.61 | 09/12/2018 | D | 80,646 (3) | 02/28/2015 | 02/28/2022 | Common Shares | 80,646 | $ 57.6 | 0 | D | ||||
Employee Stock Option (Right to buy) | $ 28.64 | 09/12/2018 | D | 65,948 (3) | 02/28/2016 | 02/28/2023 | Common Shares | 65,948 | $ 57.6 | 0 | D | ||||
Employee Stock Option (Right to buy) | $ 30.4 | 09/12/2018 | D | 63,954 (3) | 02/28/2017 | 02/28/2024 | Common Shares | 63,954 | $ 57.6 | 0 | D | ||||
Employee Stock Option (Right to buy) | $ 36.2 | 09/12/2018 | D | 83,714 (3) | 02/28/2018 | 02/28/2025 | Common Shares | 83,714 | $ 57.6 | 0 | D | ||||
Employee Stock Option (Right to buy) | $ 34.64 | 09/12/2018 | D | 91,820 (3) | 02/28/2019 | 02/28/2026 | Common Shares | 91,820 | $ 57.6 | 0 | D | ||||
Employee Stock Option (Right to buy) | $ 40.49 | 09/12/2018 | D | 40,802 (3) | 02/28/2020 | 02/28/2027 | Common Shares | 40,802 | $ 57.6 | 0 | D | ||||
Employee Stock Option (Right to buy) | $ 42.31 | 09/12/2018 | D | 21,277 (3) | 02/28/2021 | 02/28/2028 | Common Shares | 21,277 | $ 57.6 | 0 | D | ||||
Restricted Stock Units | (4) | 09/12/2018 | D | 4,528 (5) | (6) | (6) | Common Shares | 4,528 | $ 57.6 | 0 | D | ||||
Dividend Equivalent Rights | (7) | 09/12/2018 | D | 138.12 (8) | (7) | (7) | Common Shares | 138.12 | $ 57.6 | 0 | D | ||||
Restricted Stock Units | (4) | 09/12/2018 | D | 5,200 (5) | (9) | (9) | Common Shares | 5,200 | $ 57.6 | 0 | D | ||||
Dividend Equivalent Rights | (7) | 09/12/2018 | D | 41.18 (8) | (7) | (7) | Common Shares | 41.18 | $ 57.6 | 0 | D |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
Romann Gould Kirstin ONE BERMUDIANA ROAD HAMILTON, D0 HM 08 |
General Counsel & Secretary |
H. Matthew Crusey, Attorney-in-Fact for Kirstin Gould | 09/14/2018 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | Disposed of following the completion of the merger (the "Merger") described in the Agreement and Plan of Merger, dated as of March 5, 2018, by and among AXA SA, Camelot Holdings Ltd. and the Issuer. At the effective time of the Merger, each issued and outstanding common share of XL Group Ltd was automatically cancelled and converted into the right to receive $57.60 in cash (the "Merger Consideration"). |
(2) | Includes all common shares held directly by the Reporting Person immediately prior to the Merger and which were automatically cancelled and converted into the right to receive the Merger Consideration. |
(3) | At the effective time of the Merger, each option to purchase common shares granted by XL Group Ltd outstanding and unexercised immediately prior to the effective time of the Merger (whether or not vested or exercisable) vested in full, was cancelled and was converted into the right to receive an amount in cash equal to the excess, if any, of the Merger Consideration over the per share exercise price of such option, multiplied by the number of common shares subject to such option immediately prior to the effective time of the Merger. |
(4) | Each restricted stock unit represents a contingent right to receive one common share. |
(5) | At the effective time of the Merger, each restricted stock unit granted by XL Group Ltd outstanding immediately prior to the effective time of the Merger (whether or not vested) vested in full, was automatically cancelled and converted into the right to receive the Merger Consideration. |
(6) | At the time of grant, restricted stock units granted on February 28, 2017 were scheduled to vest in three equal annual installments on each anniversary of the grant date (February 28, 2018, 2019 and 2020). |
(7) | The dividend equivalent rights accrued when and as dividends were paid on common shares. Each dividend equivalent right is the economic equivalent of one common share. |
(8) | At the effective time of the Merger, each dividend equivalent right accrued and outstanding prior to the effective time of the Merger (whether or not vested) vested in full, was automatically cancelled and converted into the right to receive the Merger Consideration. |
(9) | At the time of grant, restricted stock units granted on February 28, 2018 were scheduled to vest in three equal annual installments on each anniversary of the grant date (February 28, 2019, 2020 and 2021). |